Top Buy
| Security | Buy | Sell | Buy (1M) | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Alnylam Pharmace. | 35 | 0 | 3 | 0 | €136.05 | €236.30 | 73.685% |
| Neurocrine Bioscience | 21 | 0 | 1 | 0 | €136.05 | €137.10 | 0.772% |
| Icon plc | 15 | 0 | 3 | 0 | €281.70 | €318.32 | 13.000% |
| Exelixis Inc. | 15 | 0 | 0 | 0 | €21.57 | €26.01 | 20.567% |
| United Therapeutics | 15 | 0 | 0 | 0 | €222.00 | €289.92 | 30.595% |
| Ultragenyx Pharmaceutical Inc. | 15 | 1 | 2 | 0 | €39.80 | €84.74 | 112.925% |
| Insulet Corp. | 14 | 0 | 1 | 0 | €157.00 | €215.54 | 37.285% |
| Merit Medical Systems | 13 | 0 | 2 | 0 | €68.00 | €86.72 | 27.525% |
| Amedisys Inc. | 13 | 0 | 3 | 0 | €83.50 | €92.26 | 10.491% |
| Halozyme Therapeutics Inc. | 12 | 0 | 1 | 0 | €36.37 | €54.21 | 49.051% |
| Repligen Corp. | 12 | 0 | 0 | 0 | €160.00 | €182.96 | 14.350% |
| QIAGEN NV | 9 | 0 | 0 | 0 | €40.47 | €47.44 | 17.223% |
| Xencor Inc. | 9 | 1 | 1 | 0 | €17.30 | €31.74 | 83.462% |
| Bio-Techne Corp. | 8 | 0 | 0 | 0 | €59.00 | €75.80 | 28.475% |
| MorphoSys AG | 7 | 0 | 0 | 0 | €67.70 | €65.00 | -3.988% |
| Gerresheimer AG | 7 | 0 | 1 | 0 | €101.80 | €110.00 | 8.055% |
| Ensign Group Inc. | 7 | 0 | 0 | 0 | €112.00 | €116.00 | 3.571% |
| Horizon Pharma plc | 7 | 0 | 0 | 0 | €110.40 | - | - |
| Medpace Holdings Inc | 7 | 0 | 1 | 0 | €350.40 | €419.64 | 19.759% |
| Masimo Corp. | 7 | 1 | 3 | 0 | €130.05 | €147.62 | 13.507% |
| LivaNova plc | 6 | 0 | 1 | 0 | €48.40 | €64.66 | 33.593% |
| Bruker Corp. | 7 | 1 | 0 | 1 | €73.66 | €85.68 | 16.324% |
| Agios Pharmaceuticals Inc. | 5 | 0 | 2 | 0 | €28.40 | €32.49 | 14.417% |